Natural and synthetic sex hormones: Effects on higher-order cognitive function and prepulse inhibition

Biological Psychology

Volumn 93, Issue 1, 2013, Pages 17-23

  Gogos, Andrea ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cognition; Estrogen; Female; Gender differences; Male; Menstrual cycle; Oral contraceptive pill (OC); PPI; Progesterone; RBANS

Indexed keywords

CYPROTERONE ACETATE; DIENOGEST; DROSPIRENONE; ESTRADIOL; ETHINYLESTRADIOL; LEVONORGESTREL; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEX HORMONE;

ADULT; ARTICLE; ATTENTION; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPTH PERCEPTION; ELECTROMYOGRAM; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN EXPERIMENT; LANGUAGE; LEARNING; MALE; MEMORY; MENSTRUAL CYCLE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NORMAL HUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; STARTLE REFLEX;

ADULT; ATTENTION; COGNITION; CONTRACEPTIVES, ORAL, COMBINED; CROSS-SECTIONAL STUDIES; ELECTROMYOGRAPHY; FEMALE; HUMANS; LANGUAGE; MALE; MEMORY; MENSTRUAL CYCLE; NEUROPSYCHOLOGICAL TESTS;

EID: 84874367392     PISSN: 03010511     EISSN: 18736246     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2013.02.001     Document Type: Article

References (57)

1. Bannbers E., Kask K., Wikstrom J., Sundstrom Poromaa I. Lower levels of prepulse inhibition in luteal phase cycling women in comparison with postmenopausal women. Psychoneuroendocrinology 2010, 35:422-429.
2. Bayer U., Hausmann M. Estrogen therapy affects right hemisphere functioning in postmenopausal women. Hormones and Behavior 2009, 55:228-234.
3. Beatty W.W., Mold J.W., Gontkovsky S.T. RBANS performance: influences of sex and education. Journal of Clinical and Experimental Neuropsychology 2003, 25:1065-1069.
4. Borgstrom A., Kask K., Gulinello M., Odlind V., Sundstrom-Poromaa I. Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls. Psychoneuroendocrinology 2008, 33:487-496.
5. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Archives of General Psychiatry 1990, 47:181-188.
6. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001, 156:234-258.
7. Burkman R., Bell C., Serfaty D. The evolution of combined oral contraception: improving the risk-to-benefit ratio. Contraception 2011, 84:19-34.
8. Chavez C., Hollaus M., Scarr E., Pavey G., Gogos A., van den Buuse M. The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study. Brain Research 2010, 1321:51-59.
9. Cicinelli E., De Tommaso M., Cianci A., Colacurci N., Rella L., Loiudice L., Cicinelli M.V., Livrea P. Oral contraceptive therapy modulates hemispheric asymmetry in spatial attention. Contraception 2011, 84:634-636.
10. Craig M.C., Murphy D.G. Estrogen therapy and Alzheimer's dementia. Annals of the New York Academy of Sciences 2010, 1205:245-253.
11. Csomor P.A., Stadler R.R., Feldon J., Yee B.K., Geyer M.A., Vollenweider F.X. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 2008, 33:497-512.
12. Della Casa V., Hofer I., Weiner I., Feldon J. The effects of smoking on acoustic prepulse inhibition in healthy men and women. Psychopharmacology 1998, 137:362-368.
13. DiLiberti C.E., O'Leary C.M., Hendy C.H., Waters D.H., Margolis M.B. Steady-state pharmacokinetics of an extended-regimen oral contraceptive with continuous estrogen. Contraception 2011, 83:55-61.
14. Fitzgerald C., Elstein M., Spona J. Effect of age on the response of the hypothalamo-pituitary-ovarian axis to a combined oral contraceptive. Fertility and Sterility 1999, 71:1079-1084.
15. Ganong W.F. Review of Medical Physiology 1979, Lange Medical Publications, California, USA. ninth ed.
16. Gogos A., Joshua N., Rossell S.L. Use of the repeatable battery for the assessment of neuropsychological status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder. Australian and New Zealand Journal of Psychiatry 2010, 44:220-229.
17. Gogos A., Kwek P., Chavez C., van den Buuse M. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors. Journal of Pharmacology and Experimental Therapeutics 2010, 333:218-227.
18. 1A receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology 2006, 31:885-889.
19. Gogos A., Van den Buuse M. Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin. Journal of Pharmacology and Experimental Therapeutics 2004, 309:267-274.
20. Gogos A., van den Buuse M., Rossell S. Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI. International Journal of Neuropsychopharmacology 2009, 12:1249-1259.
21. Griksiene R., Ruksenas O. Effects of hormonal contraceptives on mental rotation and verbal fluency. Psychoneuroendocrinology 2011, 36:1239-1248.
22. Hampson E. Variations in sex-related cognitive abilities across the menstrual cycle. Brain and Cognition 1990, 14:26-43.
23. Holstein D.H., Csomor P.A., Geyer M.A., Huber T., Brugger N., Studerus E., Vollenweider F.X. The effects of sertindole on sensory gating, sensorimotor gating, and cognition in healthy volunteers. Journal of Psychopharmacology 2011, 25:1600-1613.
24. Joffe H., Hall J.E., Gruber S., Sarmiento I.A., Cohen L.S., Yurgelun-Todd D., Martin K.A. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 2006, 13:411-422.
25. Jovanovic T., Szilagyi S., Chakravorty S., Fiallos A.M., Lewison B.J., Parwani A., Schwartz M.P., Gonzenbach S., Rotrosen J.P., Duncan E.J. Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology 2004, 41:401-406.
26. Kask K., Backstrom T., Gulinello M., Sundstrom-Poromaa I. Lower levels of prepulse inhibition of startle response in pregnant women compared to postpartum women. Psychoneuroendocrinology 2008, 33:100-107.
27. Kask K., Gulinello M., Backstrom T., Geyer M.A., Sundstrom-Poromaa I. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle. Neuropsychopharmacology 2008, 33:2283-2290.
28. Kishi T., Fukuo Y., Okochi T., Kawashima K., Moriwaki M., Furukawa O., Fujita K., Musso G.M., Correll C.U., Kane J.M., Iwata N. The relationship between acoustic startle response measures and cognitive functions in Japanese patients with schizophrenia. Neuromolecular Medicine 2012, 14:131-138.
29. Kumari V., Aasen I., Papadopoulos A., Bojang F., Poon L., Halari R., Cleare A.J. A comparison of prepulse inhibition in pre- and postmenopausal women and age-matched men. Neuropsychopharmacology 2008, 33:2610-2618.
30. Kumari V., Aasen I., Sharma T. Sex differences in prepulse inhibition deficits in chronic schizophrenia. Schizophrenia Research 2004, 69:219-235.
31. Kumari V., Konstantinou J., Papadopoulos A., Aasen I., Poon L., Halari R., Cleare A.J. Evidence for a role of progesterone in menstrual cycle-related variability in prepulse inhibition in healthy young women. Neuropsychopharmacology 2010, 35:929-937.
32. LeBlanc E.S., Janowsky J., Chan B.K., Nelson H.D. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001, 285:1489-1499.
33. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 2006, 138:1027-1030.
34. Maki P.M., Rich J.B., Rosenbaum R.S. Implicit memory varies across the menstrual cycle: estrogen effects in young women. Neuropsychologia 2002, 40:518-529.
35. Maki P.M., Sundermann E. Hormone therapy and cognitive function. Human Reproduction Update 2009, 15:667-681.
36. Maylor E.A., Reimers S., Choi J., Collaer M.L., Peters M., Silverman I. Gender and sexual orientation differences in cognition across adulthood: age is kinder to women than to men regardless of sexual orientation. Archives of Sexual Behavior 2007, 36:235-249.
37. Mordecai K.L., Rubin L.H., Maki P.M. Effects of menstrual cycle phase and oral contraceptive use on verbal memory. Hormones and Behavior 2008, 54:286-293.
38. Nelson H.E. The National Adult Reading Test (NART) 1982, NFER, Windsor.
39. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
40. Postma P., Gray J.A., Sharma T., Geyer M., Mehrotra R., Das M., Zachariah E., Hines M., Williams S.C., Kumari V. A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology 2006, 184:589-599.
41. Rahman Q., Abrahams S., Wilson G.D. Sexual-orientation-related differences in verbal fluency. Neuropsychology 2003, 17:240-246.
42. Rahman Q., Kumari V., Wilson G.D. Sexual orientation-related differences in prepulse inhibition of the human startle response. Behavioral Neuroscience 2003, 117:1096-1102.
43. Rahman Q., Wilson G.D., Abrahams S. Sexual orientation related differences in spatial memory. Journal of the International Neuropsychological Society: JINS 2003, 9:376-383.
44. Randolph, C., 1998. Repeatable Battery for the Assessment of Neuropsychological Status (RBANSô), Florida, USA.
45. Rapkin A.J., Biggio G., Concas A. Oral contraceptives and neuroactive steroids. Pharmacology Biochemistry and Behavior 2006, 84:628-634.
46. Rivera R., Yacobson I., Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. American Journal of Obstetrics and Gynecology 1999, 181:1263-1269.
47. Rosenberg L., Park S. Verbal and spatial functions across the menstrual cycle in healthy young women. Psychoneuroendocrinology 2002, 27:835-841.
48. Ross G.T., Vande Wiele R.L. The ovaries. Textbook of Endocrinology 1974, 368-393. W. B. Saunders, Philadelphia. fifth ed. R.H. Williams (Ed.).
49. Roussos P., Giakoumaki S.G., Bitsios P. Tolcapone effects on gating, working memory, and mood interact with the synonymous catechol-O-methyltransferase rs4818c/g polymorphism. Biological Psychiatry 2009, 66:997-1004.
50. Sherwin B.B. Estrogen and cognitive functioning in women: lessons we have learned. Behavioral Neuroscience 2012, 126:123-127.
51. Swerdlow N.R., Auerbach P., Monroe S.M., Hartston H., Geyer M.A., Braff D.L. Men are more inhibited than women by weak prepulses. Biological Psychiatry 1993, 34:253-260.
52. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 2001, 156:194-215.
53. Swerdlow N.R., Hartman P.L., Auerbach P.P. Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biological Psychiatry 1997, 41:452-460.
54. Ventura J., Green M.F., Shaner A., Liberman R.P. Training and quality assurance with the brief psychiatric rating scale: the drift busters. International Journal of Methods in Psychiatric Research 1993, 3:221-244.
55. Wharton W., Hirshman E., Merritt P., Doyle L., Paris S., Gleason C. Oral contraceptives and androgenicity: influences on visuospatial task performance in younger individuals. Experimental Clinical Psychopharmacology 2008, 16:156-164.
56. Yusuf F., Siedlecky S. Patterns of contraceptive use in Australia: analysis of the 2001 National Health Survey. Journal of Biosocial Science 2007, 39:735-744.
57. Zec R.F., Trivedi M.A. The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review. Neuropsychology Review 2002, 12:65-109.